Rosacea: Clinical Trials

40 trials for Rosacea, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

40 completed. 40 Phase 2, 5 Phase 1, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 240Completed 40
Phase 15Completed 5
Phase 32Completed 2

Follow Rosacea: new trials by email Literature Review of Rosacea trials Research Report on Rosacea

Trials (filtered) newest first · largest first

All 40 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Potassium-titanyl Phosphate (KTP) Laser vs KTP Laser and Ivermectin Cream for Facial Rosacea
KTP laser, Ivermectin 1% cream - Rosacea
Phase 2CompletedInsel Gruppe AG, University Hospital Bern222023-09-122024-12-06
Study of TP-04 in Participants With Papulopustular Rosacea
Lotilaner Gel, 2.0%, Vehicle control gel - Papulopustular Rosacea
Phase 2CompletedTarsus Pharmaceuticals, Inc.372023-03-012023-11-24
Evaluation of the Safety and Efficacy of Topical Roflumilast Cream in the Treatment of Facial Papulopustular Rosacea
Roflumilast Cream - Rosacea
Phase 2CompletedDermatology Consulting Services, PLLC402022-04-152023-05-31
Safety, Efficacy and Pharmacokinetics of Rifaximin in Patients With Moderate-to-severe Papulopustular Rosacea
Rifaximin, Placebo - Papulopustular Rosacea
Phase 2CompletedAlfasigma S.p.A.2162021-10-052024-04-24
Therapeutic Effects of Topical Herbal Medicine -Rhubarb Ointment on Rosacea
dian dao san - Rosacea, Chinese Herbal Medicine
Phase 2CompletedChang Gung Memorial Hospital242021-08-042025-04-01
CGB-400 Topical Gel for the Treatment of Inflammatory Lesions of Rosacea
CGB-400, Vehicle Gel - Rosacea
Phase 2CompletedCAGE Bio Inc.782021-05-072026-04-01
Rosacea and Ivermectin
ivermectin, digital interaction, GPSkin - Rosacea
Phase 2CompletedWake Forest University Health Sciences302021-04-162026-03-27
A Study to Determine Safety and Efficacy of B244 in Subjects With Mild to Moderate Rosacea
B244, Vehicle - Rosacea
Phase 2CompletedAOBiome LLC1402018-07-022022-09-16
Safety and Efficacy of ACU-D1 in the Treatment of Acne Rosacea
ACCU-D1, Vehicle - Acne Rosacea
Phase 2CompletedAccuitis, Inc.402017-11-282021-08-23
Study to Evaluate the Safety and Efficacy of Topical Minocycline Gel in Patients With Papulopustular Rosacea
1% Topical Minocycline Gel, 3% Topical Minocycline Gel, Topical Vehicle Gel - Rosacea, Papulopustular Rosacea
Phase 2CompletedHovione Scientia Limited2702017-10-302019-11-08
A Controlled Study to Assess the Efficacy, Safety and Tolerability of Oral DFD-29 Extended Release Capsules
DFD-29 Extended Release Capsules (40 mg), DFD-29 Extended Release Capsules (20 mg), Oraycea® (doxycycline) Capsules - Rosacea
Phase 2CompletedDr. Reddy's Laboratories Limited2052017-10-012021-03-01
Open Label Study to Assess the Effect of Secukinumab in Moderate to Severe Papulopustular Rosacea
Secukinumab - Papulopustular Rosacea
Phase 1 / Phase 2CompletedAnne Chang242017-06-212020-02-05
DMT210 Topical Gel in the Treatment of Acne Rosacea
DMT210 Topical Gel 5%, Vehicle Control - Acne Rosacea
Phase 2CompletedDermata Therapeutics1072017-01-012018-04-18
A Study to Assess the Efficacy, Safety and Tolerability of DFD-04
DFD-04 Ointment, Placebo Ointment - Rosacea
Phase 2CompletedDr. Reddy's Laboratories Limited612016-07-012019-01-23
Evaluation of the Inhibitory Effects of Topical Ivermectin on Markers of Rosacea Specific Inflammation.
Ivermectin - Rosacea
Phase 1 / Phase 2CompletedUniversity of California, San Diego252016-07-012021-10-05
Safety and Efficacy Study of a Topical Minocycline Foam in Patients With Papulopustular Rosacea
FMX-103 1.5%, FMX-103 3%, Vehicle foam (0%) - Rosacea, Papulopustular Rosacea
Phase 2CompletedVyne Therapeutics Inc.2332015-09-012017-02-15
A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Rosacea
PAC-14028 cream 0.1%, PAC-14028 cream 0.3%, PAC-14028 cream 1.0% - Rosacea
Phase 2CompletedAmorepacific Corporation2162014-10-012016-09-20
Effect of CD07805/47 Gel in Rosacea Flushing
CD07805/47, CD07805/47+Placebo, Placebo, CD07805/47, Placebo, Placebo, CD07805/47+Placebo, CD07805/47, CD07805/47, Placebo, CD07805/47, CD07805/47+Placebo, Placebo, Placebo, CD07805/47 - Rosacea
Phase 2CompletedGalderma R&D342014-04-012016-10-20
A Safety and Efficacy Study of DRM02 in Subjects With Rosacea
DRM02, Vehicle - Rosacea
Phase 2CompletedDermira, Inc.302013-10-012021-07-20
An Analysis of the Effect of Topical Cromolyn Sodium on Rosacea-associated Erythema
Cromolyn Sodium, Normal Saline - Papulopustular Rosacea
Phase 1 / Phase 2CompletedUniversity of California, San Diego102013-08-012019-08-07

Showing 20 of 40. Sign in to see all of them.

Narrower conditions

Erythema (4)  ·  Acne Vulgaris (2)  ·  Skin Diseases (2)  ·  Telangiectasis (2)  ·  Corneal Neovascularization (1)  ·  Dermatitis, Atopic (1)  ·  Dermatitis, Seborrheic (1)  ·  Flushing (1)  ·  cyclopia sequence (1)

Broader conditions

Skin and Connective Tissue Diseases (40)  ·  Skin Diseases (38)  ·  Pathological Conditions, Signs and Symptoms (5)  ·  Signs and Symptoms (4)  ·  Skin Manifestations (4)  ·  Acneiform Eruptions (2)  ·  Cardiovascular Diseases (2)  ·  Sebaceous Gland Diseases (2)  ·  Vascular Diseases (2)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Corneal Diseases (1)  ·  Dermatitis (1)  ·  Eye Diseases (1)  ·  Genetic Diseases, Inborn (1)  ·  Hypersensitivity (1)

Interventions

Ivermectin (3)  ·  Gels (2)  ·  azelaic acid (2)  ·  Benchmarking (1)  ·  Capsules (1)  ·  Cromolyn Sodium (1)  ·  Dapsone (1)  ·  Doxycycline (1)  ·  Lasers, Solid-State (1)  ·  Metronidazole (1)  ·  N-(1-(3,5-difluoro-4-methanesulfonylaminophenyl)ethyl)-3-(2-propyl-6-trifluoromethylpyridine-3-yl)acrylamide (1)  ·  Ointments (1)  ·  Omiganan (1)  ·  Oxygen (1)  ·  Rifaximin (1)

Sponsors

Galderma R&D (3)  ·  Allergan (2)  ·  Amorepacific Corporation (2)  ·  Dr. Reddy's Laboratories Limited (2)  ·  LEO Pharma (2)  ·  University of California, San Diego (2)  ·  AOBiome LLC (1)  ·  Accuitis, Inc. (1)  ·  Alfasigma S.p.A. (1)  ·  Anne Chang (1)  ·  Aria Aesthetics Inc. (1)  ·  CAGE Bio Inc. (1)  ·  Chang Gung Memorial Hospital (1)  ·  Coria Laboratories, Ltd. (1)  ·  DeNova Research (1)

Countries

United States (30)  ·  Germany (4)  ·  Canada (2)  ·  South Korea (2)  ·  Switzerland (1)  ·  Taiwan (1)

Top investigators

Michael Graeber, MD (2)  ·  Alan Fleischer, MD (1)  ·  Alexa Kimball, MD, MPH (1)  ·  Andrew Pollack, MD (1)  ·  Angela Moore, MD (1)  ·  Anne Chang, MD (1)  ·  BeomJoon Kim, Professor (1)  ·  Beth Zib (1)  ·  Daniel M Stewart, DO (1)  ·  Dow Stough, MD (1)  ·  Eduardo Tschen, MD (1)  ·  Fran Cook-Bolden, MD (1)  ·  Gerald D Weinstein, MD (1)  ·  Girish Munavalli, MD (1)

Results publications

PMID 22395584, PMID 23233252, PMID 29396702, PMID 34076401, PMID 35096250, PMID 41778357